GE Healthcare, LLC recalls GE Pristina Serena - Product Usage: Pristina Serena is an optional accessory of Senographe Pristina intended to provide…
- Recall date
- May 16, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2132-2019
- FDA classification
- Class II
- Brand / firm
- GE Healthcare, LLC
- Sold / distributed
- Worldwide distribution - US nationwide distribution in the states of AZ, CA, FL, GA, IL, MI, MN, NC, NJ, NY, PA, TX, and VT, and countries of Algeria, Australia, Belgium, Canada, Chile, Columbia, Czech Republic, Finland, France, Germany, Hungary, Iceland, Japan, Korea (Republic of), Kuwait, Lebanon…
Why it was recalled
Potential slippage of the biopsy positioner when the gantry is rotated during a biopsy procedure.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
GE Pristina Serena - Product Usage: Pristina Serena is an optional accessory of Senographe Pristina intended to provide accurate location of lesions in the breast in three dimensions.
Get recall alerts
Free email alert whenever GE Healthcare, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: GE Healthcare, LLC